These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 8822271

  • 1. Follistatins neutralize activin bioactivity by inhibition of activin binding to its type II receptors.
    de Winter JP, ten Dijke P, de Vries CJ, van Achterberg TA, Sugino H, de Waele P, Huylebroeck D, Verschueren K, van den Eijnden-van Raaij AJ.
    Mol Cell Endocrinol; 1996 Jan 15; 116(1):105-14. PubMed ID: 8822271
    [Abstract] [Full Text] [Related]

  • 2. Truncated activin type II receptors inhibit bioactivity by the formation of heteromeric complexes with activin type I. receptors.
    De Winter JP, De Vries CJ, Van Achterberg TA, Ameerun RF, Feijen A, Sugino H, De Waele P, Huylebroeck D, Verschueren K, Van Den Eijden-Van Raaij AJ.
    Exp Cell Res; 1996 May 01; 224(2):323-34. PubMed ID: 8612709
    [Abstract] [Full Text] [Related]

  • 3. A novel role of follistatin, an activin-binding protein, in the inhibition of activin action in rat pituitary cells. Endocytotic degradation of activin and its acceleration by follistatin associated with cell-surface heparan sulfate.
    Hashimoto O, Nakamura T, Shoji H, Shimasaki S, Hayashi Y, Sugino H.
    J Biol Chem; 1997 May 23; 272(21):13835-42. PubMed ID: 9153241
    [Abstract] [Full Text] [Related]

  • 4. Difference between follistatin isoforms in the inhibition of activin signalling: activin neutralizing activity of follistatin isoforms is dependent on their affinity for activin.
    Hashimoto O, Kawasaki N, Tsuchida K, Shimasaki S, Hayakawa T, Sugino H.
    Cell Signal; 2000 Aug 23; 12(8):565-71. PubMed ID: 11027950
    [Abstract] [Full Text] [Related]

  • 5. Molecular heterogeneity of follistatin, an activin-binding protein. Higher affinity of the carboxyl-terminal truncated forms for heparan sulfate proteoglycans on the ovarian granulosa cell.
    Sugino K, Kurosawa N, Nakamura T, Takio K, Shimasaki S, Ling N, Titani K, Sugino H.
    J Biol Chem; 1993 Jul 25; 268(21):15579-87. PubMed ID: 8340384
    [Abstract] [Full Text] [Related]

  • 6. Characterization of inhibin/activin subunit, follistatin, and activin type II receptors in human ovarian cancer cell lines: a potential role in autocrine growth regulation.
    Di Simone N, Crowley WF, Wang QF, Sluss PM, Schneyer AL.
    Endocrinology; 1996 Feb 25; 137(2):486-94. PubMed ID: 8593793
    [Abstract] [Full Text] [Related]

  • 7. Identification and characterization of binding proteins for inhibin and activin in human serum and follicular fluids.
    Krummen LA, Woodruff TK, DeGuzman G, Cox ET, Baly DL, Mann E, Garg S, Wong WL, Cossum P, Mather JP.
    Endocrinology; 1993 Jan 25; 132(1):431-43. PubMed ID: 7678220
    [Abstract] [Full Text] [Related]

  • 8. Follistatin and its role as an activin-binding protein.
    Sugino H, Sugino K, Hashimoto O, Shoji H, Nakamura T.
    J Med Invest; 1997 Aug 25; 44(1-2):1-14. PubMed ID: 9395712
    [Abstract] [Full Text] [Related]

  • 9. A two-site chemiluminescent assay for activin-free follistatin reveals that most follistatin circulating in men and normal cycling women is in an activin-bound state.
    McConnell DS, Wang Q, Sluss PM, Bolf N, Khoury RH, Schneyer AL, Midgley AR, Reame NE, Crowley WF, Padmanabhan V.
    J Clin Endocrinol Metab; 1998 Mar 25; 83(3):851-8. PubMed ID: 9506739
    [Abstract] [Full Text] [Related]

  • 10. Isolation and characterization of native activin B.
    Nakamura T, Asashima M, Eto Y, Takio K, Uchiyama H, Moriya N, Ariizumi T, Yashiro T, Sugino K, Titani K.
    J Biol Chem; 1992 Aug 15; 267(23):16385-9. PubMed ID: 1644823
    [Abstract] [Full Text] [Related]

  • 11. Inhibins, activins, and follistatins: expression of mRNAs and cellular localization in tissues from men with benign prostatic hyperplasia.
    Thomas TZ, Chapman SM, Hong W, Gurusingfhe C, Mellor SL, Fletcher R, Pedersen J, Risbridger GP.
    Prostate; 1998 Jan 01; 34(1):34-43. PubMed ID: 9428386
    [Abstract] [Full Text] [Related]

  • 12. Follistatin-activin complexes in human serum and follicular fluid differ immunologically and biochemically.
    Schneyer AL, Hall HA, Lambert-Messerlian G, Wang QF, Sluss P, Crowley WF.
    Endocrinology; 1996 Jan 01; 137(1):240-7. PubMed ID: 8536619
    [Abstract] [Full Text] [Related]

  • 13. Osteogenic protein-1 binds to activin type II receptors and induces certain activin-like effects.
    Yamashita H, ten Dijke P, Huylebroeck D, Sampath TK, Andries M, Smith JC, Heldin CH, Miyazono K.
    J Cell Biol; 1995 Jul 01; 130(1):217-26. PubMed ID: 7790373
    [Abstract] [Full Text] [Related]

  • 14. Follistatin-related protein and follistatin differentially neutralize endogenous vs. exogenous activin.
    Sidis Y, Tortoriello DV, Holmes WE, Pan Y, Keutmann HT, Schneyer AL.
    Endocrinology; 2002 May 01; 143(5):1613-24. PubMed ID: 11956142
    [Abstract] [Full Text] [Related]

  • 15. Pituitary activin receptor subtypes and follistatin gene expression in female rats: differential regulation by activin and follistatin.
    Dalkin AC, Haisenleder DJ, Yasin M, Gilrain JT, Marshall JC.
    Endocrinology; 1996 Feb 01; 137(2):548-54. PubMed ID: 8593801
    [Abstract] [Full Text] [Related]

  • 16. Identification of activins and follistatin proteins in human follicular fluid and placenta.
    Yokoyama Y, Nakamura T, Nakamura R, Irahara M, Aono T, Sugino H.
    J Clin Endocrinol Metab; 1995 Mar 01; 80(3):915-21. PubMed ID: 7883850
    [Abstract] [Full Text] [Related]

  • 17. Tissue-specific binding of radiolabeled activin A by activin receptors and follistatin in postimplantation rat and mouse embryos.
    Roberts VJ, Bentley CA, Guo Q, Matzuk MM, Woodruff TK.
    Endocrinology; 1996 Oct 01; 137(10):4201-9. PubMed ID: 8828478
    [Abstract] [Full Text] [Related]

  • 18. Activin and follistatin as local regulators in the human ovary.
    Peng C, Ohno T, Khorasheh S, Leung PC.
    Biol Signals; 1996 Oct 01; 5(2):81-9. PubMed ID: 8836491
    [Abstract] [Full Text] [Related]

  • 19. Cell survival effect of activin against heat shock stress on OVCAR3.
    Fukuda J, Ito I, Tanaka T, Leung PC.
    Life Sci; 1998 Oct 01; 63(25):2209-20. PubMed ID: 9870706
    [Abstract] [Full Text] [Related]

  • 20. Activin A in JEG-3 cells: potential role as an autocrine regulator of steroidogenesis in humans.
    Ni X, Luo S, Minegishi T, Peng C.
    Biol Reprod; 2000 May 01; 62(5):1224-30. PubMed ID: 10775170
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.